Factors Associated with Adherence to Adjuvant Endocrine Therapy Among Privately Insured and Newly Diagnosed Breast Cancer Patients: A Quantile Regression AnalysisThe Economic Impact of Opioid Use in the Management of Chronic Nonmalignant PainImproving the Efficiency and Quality of the Value Assessment Process for Companion Diagnostic Tests: The Companion test Assessment Tool (CAT)Identifying the Optimal Role for Pharmacists in Care Transitions: A Systematic ReviewCurrent drug therapies for rosacea: a chronic vascular and inflammatory skin diseaseNew Therapeutic Paradigms and Guidelines in the Management of Pulmonary Arterial HypertensionChallenges to integrating pharmacogenetic testing into medication therapy managementA Systematic Review of Insulin Adherence Measures in Patients with Diabetes.Pharmacy Benefits Management in the Veterans Health Administration Revisited: A Decade of Advancements, 2004-2014.Clopidogrel-Proton Pump Inhibitor Drug-Drug Interaction and Risk of Adverse Clinical Outcomes Among PCI-Treated ACS Patients: A Meta-analysis.Geographic Variation in Rosiglitazone Use Surrounding FDA Warnings in the Department of Veterans AffairsA Systematic Review of PCSK9 Inhibitors Alirocumab and Evolocumab.A Systematic Review of Evidence-Based Community Pharmacy Services Aimed at the Prevention of Cardiovascular Disease.Impact of adherence and weight loss on glycemic control in patients with type 2 diabetes: cohort analyses of integrated medical record, pharmacy claims, and patient-reported data.Geospatial analysis of statin adherence using pharmacy claims data in the state of Michigan.Utilizing data consortia to monitor safety and effectiveness of biosimilars and their innovator products.Assessment of the Level of Satisfaction and Unmet Data Needs for Specialty Drug Formulary Decisions in the United States.Low-Cost Generic Program Use by Medicare Beneficiaries: Implications for Medication Exposure Misclassification in Administrative Claims Data.Evaluation of Specialty Drug Price Trends Using Data from Retrospective Pharmacy Sales Transactions.Estimating Generic Drug Use with Electronic Health Records Data from a Health Care Delivery System: Implications for Quality Improvement and Research.Evaluation of Real-World Experience with Tofacitinib Compared with Adalimumab, Etanercept, and Abatacept in RA Patients with 1 Previous Biologic DMARD: Data from a U.S. Administrative Claims Database.Hemophilia Management via Data Collection and Reporting: Initial Findings from the Comprehensive Care Sustainability Collaborative.Progression to Type 2 Diabetes and Its Effect on Health Care Costs in Low-Income and Insured Patients with Prediabetes: A Retrospective Study Using Medicaid Claims Data.Primary Biliary Cholangitis: Medical and Specialty Pharmacy Management Update.The pharmacist role in predicting and improving medication adherence in heart failure patients.Association of visit-to-visit variability of hemoglobin A1c and medication adherence.Role of pharmacy services in accountable care organizationsMissed opportunities for HIV screening in pharmacies and retail clinics.Treatment Patterns of Anti-Vascular Endothelial Growth Factor and Laser Therapy Among Patients with Diabetic Macular Edema.Analysis of National Drug Code Identifiers in Ambulatory E-Prescribing.Evaluating the Initiation of Novel Oral Anticoagulants in Medicare Beneficiaries.Reach and Validity of an Objective Medication Adherence Measure Among Safety Net Health Plan Members with Diabetes: A Cross-Sectional Study.Examination of the Link Between Medication Adherence and Use of Mail-Order Pharmacies in Chronic Disease States.Potential Health Implications of Medication Therapy Management Eligibility Criteria in the Patient Protection and Affordable Care Act Across Racial and Ethnic Groups.Effect of Diabetes Treatment-Related Attributes on Costs to Type 2 Diabetes Patients in a Real-World Population.Clinical Profile, Dosing, and Quality-of-Life Outcomes in Primary Immune Deficiency Patients Treated at Home with Immunoglobulin G: Data from the IDEaL Patient Registry.A Real-World Observational Study of Time to Treatment Intensification Among Elderly Patients with Inadequately Controlled Type 2 Diabetes Mellitus.Predictors of start of different antidepressants in patient charts among patients with depression.Implementation of a pharmacy-based adult vaccine benefit: recommendations for a commercial health plan benefit.The GRACE checklist for rating the quality of observational studies of comparative effectiveness: a tale of hope and caution.
P1433
Q26779595-5336CADA-798A-4916-B297-1A4B0171F253Q26781570-C0084878-A286-4A9D-8A70-D348EC476236Q26800239-3F0D5988-5BA7-4884-96AB-CE092F8A6F41Q26800242-E9F37CAB-97D2-491D-BDCC-C2FBB9F74EF3Q27002345-115171B4-0F76-44FC-9B9A-6866311DE3D5Q28079216-FF91BDA6-16A6-4F6C-94A7-13C975ADB13FQ28082835-57B844A8-0B6D-4CDE-B62E-DED3AE68D189Q30244071-F53520AA-7F57-4BE8-AA91-DC1E59E811B1Q30248225-9A73E857-E2E4-4D7F-AB72-979A01AD8A9BQ30248781-AF5301F6-1EA0-4E0C-9FE5-1340D52F1178Q30359158-5549865A-B1E3-4B21-9843-B16E123F70F5Q30388561-A818FD7C-A4F0-434A-BE51-7EDC774FE311Q30388564-9EC7236E-03C1-42F9-938E-57868AA1300FQ30833473-671FE304-B066-410B-9DA7-26D0C5554CC9Q30872830-3B6CE51C-8F56-4507-83F1-14B8BCA2CC4BQ30882909-3244D8B5-F402-4059-9C47-FA6C46EDF165Q31064631-133657C1-215C-4D37-9829-CE5324B36F06Q31102987-C56BC788-FC33-4C83-A5A4-FBA8CC1EB82AQ31125466-6DCC3293-DF5A-4875-86BF-5CC1323701E6Q31133117-F1052871-4062-46CA-9C76-023F254B17EDQ31144486-277E3A45-1514-4E2A-8244-9BCD77FAE030Q31151517-0AC3202D-BCB4-4F30-9163-1971426E558CQ31165089-7DAE6295-B7B9-4BD3-BBCC-8584FE0BF5F3Q34541933-FA30D8D6-3430-4599-BF8F-2FC6EF6B3C17Q35195322-B148245B-76CB-4921-9722-D15CA3532EDDQ35569464-34F31BC2-365D-433D-9340-871B92068B70Q35713127-23DB75ED-5C2D-4EEB-860D-01513E3C8641Q35734979-6954C837-AC0E-4597-9119-AE84A0727917Q35755726-13044BB9-CF55-4312-BB11-635226E1CCD9Q35828582-6B794471-DB59-42E8-86F5-70878DEB23C7Q35966238-2A2A47E8-1188-4C00-9A28-B8349EA3D573Q36006414-1FF82173-8622-44F1-BF47-3EA831C62C89Q36174840-F4C88E84-2C28-40B9-BD2C-C2C0CAF3901BQ36243328-64286C79-CA67-4854-8198-C77DC0751F1FQ36323497-6F63BB85-45F9-41C0-8D12-54A32F18BAB9Q36323503-76ADA070-3A4E-4352-A44E-DE114C1CB7D8Q36598424-3DB2A413-C207-41C9-8734-B72B6173D99FQ37050214-6B303C47-9021-43D3-9646-EF6FB24F54A4Q38190633-7F847A88-80AF-4C8A-A4AE-80CE4012E6CBQ38190634-1C2B41D2-BF02-4DCA-9C53-8301641A4EAE
P1433
description
academisch tijdschrift
@nl
monthy peer-reviewed medical journal covering all aspects of managed care pharmacy
@en
name
Journal of Managed Care & Specialty Pharmacy
@en
Journal of Managed Care & Specialty Pharmacy
@nl
type
label
Journal of Managed Care & Specialty Pharmacy
@en
Journal of Managed Care & Specialty Pharmacy
@nl
altLabel
J. Manag. Care Spec. Pharm.
@en
JMCP
@en
Journal of Managed Care Pharmacy
@en
prefLabel
Journal of Managed Care & Specialty Pharmacy
@en
Journal of Managed Care & Specialty Pharmacy
@nl
P243
P3181
P1055
P1156
21100370879
P1160
J. Manag. Care Spec. Pharm.
P123
P236
P243
P3181
P407
P571
1995-01-01T00:00:00Z